INKA analysis of data on EGFR‐mutant NSCLC cell line H3255 (Guo et al, 2008) uncovered major EGFR activity in these cells, with EGFR ranking first, followed by MET (Fig 4A). This evidence concerns the gene EGFR and non-small cell lung carcinoma.